Aptose Biosciences Inc (NASDAQ:APTO)

4.33
Delayed Data
As of 3:59pm ET
 -0.14 / -3.13%
Today’s Change
3.92
Today|||52-Week Range
9.25
-1.14%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$391.0M

Company Description

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.

Contact Information

Aptose Biosciences, Inc.
251 Consumers Road
Toronto Ontario M2J 4R3
P:(647) 479-9828
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

William G. RiceChairman, President & Chief Executive Officer
Gregory K. ChowChief Financial Officer & Senior Vice President
Rafael BejarChief Medical Officer & Senior Vice President
Victor Montalvo-LugoVice President-Clinical Operations
Ernest KittVice President-Development & Technical Operations